Skip to main content
. Author manuscript; available in PMC: 2011 Jan 22.
Published in final edited form as: Vaccine. 2009 Nov 13;28(4):1031. doi: 10.1016/j.vaccine.2009.10.126

Figure 4.

Figure 4

Virus-binding antibody responses induced to VEEV TrD virus by increased dosages of gV3526 vaccination. Sera were obtained from mice on Day 49 post-primary vaccination, one week prior to challenge. These data are reported as the geometric mean endpoint titers as determined by ELISA. Escalating dosages consisted of 0.15, 0.25 and 0.4 µg gV3526. All antibody titers were below detectable levels in sham-vaccinated mice. The 0.02 µg dosage of gV3526 was not tested with CpG + AlOH. Error bars represent the 95% confidence level.